Skip to main content

Miguel Montero-Baker, MD

Original Contribution
11/29/2017
Transpedal access is a novel, increasingly utilized technique for the management of complex peripheral artery disease (PAD). We performed a literature search and evaluated patient sample demographics, procedure indications, access and target...
Transpedal access is a novel, increasingly utilized technique for the management of complex peripheral artery disease (PAD). We performed a literature search and evaluated patient sample demographics, procedure indications, access and target...
Transpedal access is a novel,...
11/29/2017
Journal of Invasive Cardiology
Drs. Montero-Baker and Somerset
LINC 2022
06/09/2022
Dr. Miguel Montero-Baker and Dr. Jill Somerset introduce a study to correlate and validate a proposed scoring system for early identification of patients at risk for reinterventions.
Dr. Miguel Montero-Baker and Dr. Jill Somerset introduce a study to correlate and validate a proposed scoring system for early identification of patients at risk for reinterventions.
Dr. Miguel Montero-Baker and Dr....
06/09/2022
Vascular Disease Management
Original Contribution
01/03/2022
An evaluation of the 30-day safety and performance outcomes of the Phoenix atherectomy system (Philips Volcano Corporation) was performed in real-world patients with peripheral artery disease (PAD).
An evaluation of the 30-day safety and performance outcomes of the Phoenix atherectomy system (Philips Volcano Corporation) was performed in real-world patients with peripheral artery disease (PAD).
An evaluation of the 30-day...
01/03/2022
Journal of Invasive Cardiology
Original Contribution
06/01/2021
This analysis seeks to describe the technique of ultrasound-assisted percutaneous superficial femoral arterial access closure with a Mynx device (Cordis Corporation). The study aim was to demonstrate the technical considerations, benefits,...
This analysis seeks to describe the technique of ultrasound-assisted percutaneous superficial femoral arterial access closure with a Mynx device (Cordis Corporation). The study aim was to demonstrate the technical considerations, benefits,...
This analysis seeks to describe...
06/01/2021
Review
07/15/2021
CardioVascular
09/07/2020
There are two aspects of the Rotarex Device that shine. First, it has very efficient clot removal. For thrombectomy purposes, I think this device is great. Second, the Rotarex engages plaque in a very efficient way.
There are two aspects of the Rotarex Device that shine. First, it has very efficient clot removal. For thrombectomy purposes, I think this device is great. Second, the Rotarex engages plaque in a very efficient way.
There are two aspects of the...
09/07/2020
Cath Lab Digest